Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B

Table 4

Clinical, epidemiologic, and histological characteristics of all ETV-resistant group patients.

No.	Age (years)	Gender	Prior exposure to NA	Biopsy	Genotype	Genotypic resistance (before ETV)	Genotypic resistance (after ETV)
1	52	Male	Yes/LAM	F3A2	C	Negative	Undetectable
2	40	Male	Yes/LAM	F1A1	C	Undetectable	Undetectable
3	30	Male	Yes/LAM + ADV	F2A1	C	—	Undetectable
4	44	Male	No	F2A2	B	—	—
5	76	Male	No	—	C	—	Undetectable
6	54	Male	No	—	B	—	Undetectable
7	66	Male	No	F1A2	C	—	L180M + S202G + M204V
8	36	Male	No	F2A2	C	Negative	Undetectable
9	61	Male	No	F4A2	B	Negative	Undetectable
10	35	Male	No	F1A1	C	—	Undetectable
11	37	Male	No	F2A2	C	Negative	Undetectable
12	61	Female	No	F2A2	C	—	Undetectable
13	48	Female	No	F2A1	C	Negative	Undetectable
14	55	Male	No	—	C	Negative	Undetectable
15	42	Female	No	F2A2	C	—	Undetectable